As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...

While type 1 and type 2 diabetes typically occupy distinct places in healthcare, research is showing an increase of patients ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Finerenone use for 6 months was safe and associated with a significant 25% decrease in albuminuria for adults with type 1 diabetes and chronic kidney disease, according to data presented in the ...

Type 1 diabetes is a disease in which the body mistakenly attacks itself as the immune system destroys the pancreas's insulin ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Type 1.5 diabetes isn’t a myth. It shares features of both Type 1 and Type 2 diabetes — it develops in adults, like Type 2, but involves an autoimmune process, ...

Predicting who will develop type 1 diabetes is now cheaper and more accessible, thanks to a new tool based on research ...

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition.